|
Post by kc on May 23, 2016 21:13:39 GMT -5
KevinMik posted this on Yahoo a few minutes a it is a well produced video of they meeting.
vimeo.com/167332167
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 23, 2016 22:43:13 GMT -5
Thanks for sharing. It was very upbeat well presented. I can understand why many walked away pleased. I was impressed with Mike. I still don't know what to make of Henry.
He didn't seem to have ill motives and seemed genuine but I could have been influenced by the positive reaction from shareholders. Matt was clearly annoyed.
Way to much ass kissing. Ahh hello we are at .93 cents. The guy asking the rls question really could have taken that up a notch and should have. Still lots of questions unanswered.
|
|
|
Post by bradleysbest on May 23, 2016 23:13:45 GMT -5
I was impressed by the enthusiasm & knowledge(swag) that Castagna exudes. Dude is sharp & sounds like he has a very methodical approach to make Afrezza a success. Was nice to also hear a label change will be sought. Thx for sharing!
PS- surprised more billionaires are not getting behind MNKD
|
|
|
Post by avichen on May 23, 2016 23:28:04 GMT -5
Yup, Mike sure looks like a super star in the making. Now all we need is the numbers! nRx tRx and $$$
|
|
|
Post by avichen on May 24, 2016 0:32:56 GMT -5
I really dislike Matt, seriously, they need a new CEO.
|
|
|
Post by kc on May 24, 2016 6:38:21 GMT -5
KevinMik posted this on Yahoo a few minutes a it is a well produced video of they meeting.
vimeo.com/167332167
I was told this morning that this video was produced by MannKind. If true I appreciate your doing so so that the public and share holders can see the quality organization they are trying to put together moving forward
|
|
|
Post by madog365 on May 24, 2016 8:41:04 GMT -5
KC is that you asking the last question?
|
|
|
Post by kc on May 24, 2016 8:48:28 GMT -5
Yes my question was the last one. There was some applause but not sure if that was for me or for Matt. Perhaps it because it was the last question.
|
|
|
Post by sportsrancho on May 24, 2016 11:41:39 GMT -5
Yes my question was the last one. There was some applause but not sure if that was for me or for Matt. Perhaps it because it was the last question. It was for you! You were great. Saw Mike taking notes. Also saw a big smile on Mike's face when someone asked Matt about who RLS was. He covered it up with his hand:-)
|
|
|
Post by dreamboatcruise on May 24, 2016 15:01:50 GMT -5
Yes my question was the last one. There was some applause but not sure if that was for me or for Matt. Perhaps it because it was the last question. It was for you! You were great. Saw Mike taking notes. Also saw a big smile on Mike's face when someone asked Matt about who RLS was. He covered it up with his hand:-) Maybe they all made bets ahead of the meeting about what questions they'd get and Mike just won $100.
|
|
|
Post by madog365 on May 24, 2016 15:09:00 GMT -5
It was for you! You were great. Saw Mike taking notes. Also saw a big smile on Mike's face when someone asked Matt about who RLS was. He covered it up with his hand:-) Maybe they all made bets ahead of the meeting about what questions they'd get and Mike just won $100. Without a doubt in my mind, Matt/Mike read this forum and YMB once in a while and laugh at the wild Receptor theories.
|
|
|
Post by factspls88 on May 24, 2016 21:15:15 GMT -5
Thanks for posting! The big takeaway for me was the fact that the clamp studies can be used for label changes. That opens up a world of possibility - from improved formulary positioning to selling points with physicians to superiority claims in advertising. It could also help with raising capital. I just hope they don't run out of $$ before they can execute on it.
|
|
|
Post by lakers on May 25, 2016 1:45:30 GMT -5
Henry said he was a partner of Shanghai Hequan Mgmt fund majority-owned by China Energy Fund Committee (CEFC), registered in Hong Kong, is a non-profit and non-governmental global think-tank fully funded by CEFC China Energy Company Limited. It is committed to the research into global climate change and environmental economics, international cooperation and sustainable development and holds forums on world civilizations to explore common ethics. As an NGO in Special Consultative Status with the Economic and Social Council of the United Nations, CEFC conducts public diplomacy in the field of energy and culture to promote international cooperation and exchanges and foster philanthropy. It has joined hands with the UN in launching the “Powering the Future We Want” initiative, offering an annual grant to institutions or individuals that have demonstrated leadership and innovation in promoting sustainable energy. www.cefc-ngo.co/en/[The China Energy Company Limited is a huge conglomerate. Check out its org structure below. en.cefc.co/category/zzjg?lang=cnCorporate Profile CEFC China Energy Company Limited (hereinafter referred to as “CEFC China”) is a private collective enterprise with energy and financial services as its core business. As the corporate name implies, CEFC China speaks for credibility of the Chinese. The strategy of the company seeks to serve the national industrial interest by building a modernized “economic community” to compete as a multinational enterprise that expands cooperation in the international energy economy and achieves influence in the energy industry. In 2014, the company was on the Fortune Global 500 List and among the World’s 500 Most Influential Brands with its annual revenues exceeding RMB 220 billion. It has been awarded the “2014 Most Influential Chinese Enterprises”, and has won the title of “Top Ten Chinese Philanthropic Enterprises” for four consecutive years. en.cefc.co/category/wmdzghx?lang=cnstocktraderforgain • 12 hours ago Flag 3users liked this postsusers disliked this posts0Reply exactly what Mr. Orlosky needs to do is approach the company in the normal manner that a person would approach buying a publically traded company. He is not going to buy a Majority interest in a company that has the potential of being worth billions for $500 Million. Not sure what he was smoking but it won't happen . The perfect storm is yet to play out on MannKind. It will be a big one you can count on it. The company has too much inherent value to sell cheap. Perhaps Henry Orlosky was thinking that shareholders would appreciate his overture but everybody saw it for what it was...... A cheap bottom fishing comment.. He wants to buy a piece of the company he can buy shares on the open market to get it cheap today. Heck he can acquire a 5% interest than approach the board to buy more shares. There is a lot wrong with his approach. I agree that if he initiates a 5% stake, he can force the BoD to dialog. Let's see if CEFC starts buying in the next 60 days. After owning 5%, the fund is required to file 13G. I don't think Mnkd had a poison pill yet. I don't mind if CEFC pays a fair price, then influences China drug regulatory to fast track Afrezza as a Chinese owned med. This could open up the huge China diabetes market including Hongkong. In the meantime I expect regional partnership w/ Canada, and/or Israel, and/or Australia this year.
|
|
|
Post by reality on May 25, 2016 6:51:55 GMT -5
Meanwhile Dance Pharma already has a Chinese Partner.
Quite honestly they better get their act together by ADA as they seem to operate as if they are equivalent in size to a giant pharma like Sanofi, and I am NOT impressed at the speed they are moving. They knew since last year that Sanofi was abandoning them. they could have done ALL this work and lined up other suitors by April of this year.
Anybody ask him what those sales milestones are that allows Matt to buy a million shares at <$1 ? Is it 1000, 10000, 100000 or 1M scripts ?
|
|
|
Post by avichen on May 25, 2016 6:57:42 GMT -5
regarding the chinese market. I don't think 'be the first will always be the winner'. when it is a new product, there must be earlier failure. Dance's exubera is still huge in size, about palm size and it is not fast acting insulin. I won't feel frustrated when they enter chinese market first. let them run and mnkd will be able to learn from it and do it better.
|
|